Urine Metabolic Signature of Distal Diuretics in CKD

1680168 data points capture the urinary metabolomic fingerprint of amiloride and hydrochlorothiazide treatment in patients with stage G3-G4 chronic kidney disease. The study identified enhanced ammoniagenesis without hypokalemia and a specific oxidative stress signature linked to diuretic-induced hyponatremia. This dataset highlights the interplay between electrolyte balance and metabolic adaptations in CKD patients on distal diuretics.

Use Cases

• Identifying metabolic biomarkers for diuretic-induced hyponatremia based on oxidative stress signatures.
• Investigating ammoniagenesis pathways in CKD patients treated with distal diuretics.
• Analyzing the interplay between electrolyte balance and urinary metabolite profiles.
• Comparing the metabolic effects of amiloride versus hydrochlorothiazide in a clinical cohort.

Strengths

• Contains 1680168 metabolomic data points, providing a substantial basis for analysis.
• Released under a permissive CC-BY-4.0 license, facilitating reuse and sharing.
• Focuses on a specific, clinically relevant population (CKD stage G3-G4 patients).

Limitations

• Column names and a precise row count are not provided, limiting understanding of the data structure.
• The dataset's temporal coverage and geographic origin are not specified.
• Relies on a single, repeated description; detailed methodology and variable definitions are absent.

Provenance

Source

Crissy Rudolphi

Collection Method

Clinical assessment of urinary metabolomic fingerprint in a patient cohort.

Freshness

Last updated on 2026-03-18.